Article
Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the…
medRxiv: the preprint server for health sciences · 2020 · Andrea Giacomelli, author Gabriele Pagani, author Anna Lisa Ridolfo, author Letizia Oreni, author Federico Conti, author Laura Pezzati, author Lucia Bradanini, author Giacomo Casalini, author Cinzia Bassoli, author Valentina Morena, author Simone Passerini, author Giuliano Rizzardini, author Chiara Cogliati, author Elisa Ceriani, author Riccardo Colombo, author Stefano Rusconi, author Cristina Gervasoni, author Dario Cattaneo, author Spinello Antinori, author Massimo Galli, author
Key facts
| Title | Early administration of lopinavir/ritonavir plus hydroxychloroquine does not alter the clinical course of SARS-CoV-2 infection: a retrospective cohort study. |
|---|---|
| First author | Andrea Giacomelli, author Gabriele Pagani, author Anna Lisa Ridolfo, author Letizia Oreni, author Federico Conti, author Laura Pezzati, author Lucia Bradanini, author Giacomo Casalini, author Cinzia Bassoli, author Valentina Morena, author Simone Passerini, author Giuliano Rizzardini, author Chiara Cogliati, author Elisa Ceriani, author Riccardo Colombo, author Stefano Rusconi, author Cristina Gervasoni, author Dario Cattaneo, author Spinello Antinori, author Massimo Galli, author |
| Journal | medRxiv : the preprint server for health sciences |
| Published | Sep 22, 2020 |
| DOI | 10.1101/2020.06.05.20123299 |
| Devices mentioned | K180559 |
| Product codes mentioned | OOI, PGI |
At a glance
- 1–9 FDA submissions mentioned
- 1–9 Product codes mentioned
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About Literature
Peer-reviewed and preprint literature indexed by Orca1 and linked to the FDA submissions and product codes each article mentions. Only bibliographic details are shown here.
Source: Publisher and PubMed metadata; device mentions identified by Orca1